Jpmorgan Chase & CO APELLIS PHARMACEUTICALS INC Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024
Number of Shares
300,000
Holding current value
$0
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
N/A
300,000 New
300,000 $0
Q1 2024

Dec 26, 2024
BUY
N/A
1,561,000 New
1,561,000 $0
Q1 2024

May 10, 2024
SELL
N/A
-939,000 Reduced 37.56%
1,561,000 $0
Q4 2023

Dec 26, 2024
BUY
N/A
2,500,000 New
2,500,000 $0
Q4 2023

Feb 12, 2024
BUY
N/A
1,305,000 Added 109.21%
2,500,000 $0
Q3 2023

Nov 14, 2023
SELL
N/A
-1,386,000 Reduced 53.7%
1,195,000 $0
Q2 2023

Aug 11, 2023
BUY
N/A
2,581,000 New
2,581,000 $0
Q4 2022

Feb 13, 2023
SELL
N/A
-895,000 Reduced 87.32%
130,000 $196,000
Q3 2022

Nov 14, 2022
BUY
N/A
932,000 Added 1002.15%
1,025,000 $1.94 Million
Q2 2022

Aug 11, 2022
BUY
N/A
93,000 New
93,000 $139,000
Q1 2022

May 11, 2022
SELL
N/A
-2,884,000 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
N/A
255,000 Added 9.7%
2,884,000 $4.37 Million
Q3 2021

Nov 12, 2021
BUY
N/A
2,629,000 New
2,629,000 $3.21 Million
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email